Dextropropoxyphene hydrochloride - paracetamol

Dextropropoxyphene hydrochloride - paracetamol is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about dextropropoxyphene hydrochloride - paracetamol automatically lists related information collected from other pages of our website.

You'll find information about brands of medicines that contain this combination of active ingredients, including their consumer medicine information (CMI) leaflets by following the links below.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - dextropropoxyphene hydrochloride - paracetamol


09 Feb 2017 Di-Gesic Tablets is a brand of medicine containing the active ingredient dextropropoxyphene hydrochloride - paracetamol. Find out about side effects, who can take it and who shouldn’t use Di-Gesic Tablets by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
For health professionals (Health professional publication)
14 Oct 2013 Dextropropoxyphene-containing analgesics Di-Gesic and Doloxene will remain registered subject to new conditions.
For health professionals (Topic)
30 Aug 2013 Some medicines can increase the risk of poor outcomes for older people and should be avoided
(Media release)
02 Mar 2012 NPS has published information online for prescribers to help them prepare for the TGA's cancellation of Capadex and Paradex, two of the four medicines available in Australia containing dextropropoxyphene
For health professionals (Health professional publication)
01 Mar 2012 From 1 March 2012, two of the four available dextropropoxyphene-containing products Capadex and Paradex will be unavailable in Australia. This follows an announcement from the Therapeutic Goods Administration (TGA) in December 2011
(Media release)
22 Feb 2012 NPS issued a media release late last year supporting the TGA's decision to cancel four prescription pain relief medicines containing dextropropoxyphene from 1 March 2012.
(Media release)
24 Nov 2011 NPS has applauded the TGA's decision to cancel four prescription pain relief medicines containing dextropropoxyphene from 1 March 2012.

Medicine brands that contain dextropropoxyphene hydrochloride - paracetamol